Pulmicort
E506227
Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
All labels observed (4)
| Label | Occurrences |
|---|---|
| budesonide | 2 |
| Pulmicort canonical | 1 |
| Pulmicort Flexhaler | 1 |
| Pulmicort Respules | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5248766 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pulmicort Context triple: [AstraZeneca, notableProduct, Pulmicort]
-
A.
Symbicort
Symbicort is a prescription inhaler medication that combines a corticosteroid and a long-acting bronchodilator to manage asthma and chronic obstructive pulmonary disease (COPD).
-
B.
Denesuline
Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
-
C.
Singulair
Singulair is a prescription leukotriene receptor antagonist (montelukast) commonly used to prevent and manage asthma and allergy symptoms.
-
D.
Synagis
Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
-
E.
Xolair
Xolair is a monoclonal antibody medication used to treat moderate to severe allergic asthma and chronic spontaneous urticaria by targeting immunoglobulin E (IgE).
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Pulmicort Target entity description: Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
-
A.
Symbicort
Symbicort is a prescription inhaler medication that combines a corticosteroid and a long-acting bronchodilator to manage asthma and chronic obstructive pulmonary disease (COPD).
-
B.
Denesuline
Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
-
C.
Singulair
Singulair is a prescription leukotriene receptor antagonist (montelukast) commonly used to prevent and manage asthma and allergy symptoms.
-
D.
Synagis
Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
-
E.
Xolair
Xolair is a monoclonal antibody medication used to treat moderate to severe allergic asthma and chronic spontaneous urticaria by targeting immunoglobulin E (IgE).
- F. None of above. chosen
Statements (31)
| Predicate | Object |
|---|---|
| instanceOf |
brand name drug
ⓘ
inhaled corticosteroid ⓘ |
| advisedWith | mouth rinsing after inhalation ⓘ |
| belongsToDrugClass |
corticosteroids
ⓘ
glucocorticoids ⓘ |
| commonSideEffect |
cough
ⓘ
hoarseness ⓘ oral thrush ⓘ throat irritation ⓘ |
| developedFrom |
budesonide
ⓘ
linked to:
Pulmicort
|
| fullEffectTime | may take 1 to 2 weeks of regular use ⓘ |
| hasActiveIngredient | budesonide ⓘ |
| hasATCCode | R03BA02 ⓘ |
| hasBrandNameVariant |
Pulmicort Flexhaler
ⓘ
linked to:
Pulmicort
Pulmicort Respules ⓘ
linked to:
Pulmicort
|
| hasDosageForm |
dry powder inhaler
ⓘ
inhalation suspension ⓘ |
| hasOnsetOfAction | within 24 hours for some patients ⓘ |
| hasRouteOfAdministration | inhalation ⓘ |
| isMarketedBy | AstraZeneca ⓘ |
| isNotFor | acute asthma attacks ⓘ |
| mayBeUsedIn | pediatric patients ⓘ |
| mechanismOfAction | anti-inflammatory effect in airways ⓘ |
| reduces |
airway hyperresponsiveness
ⓘ
airway inflammation ⓘ |
| regulatoryStatus | prescription only ⓘ |
| requires | regular use for maximal benefit ⓘ |
| treats | asthma ⓘ |
| usedFor |
control of chronic asthma
ⓘ
maintenance treatment of asthma ⓘ prevention of asthma symptoms ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Pulmicort Description of subject: Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Pulmicort
linked to: Pulmicort
linked to: Pulmicort
linked to: Pulmicort